Page last updated: 2024-08-23

nimustine and Animal Mammary Carcinoma

nimustine has been researched along with Animal Mammary Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bouwman, P; Jonkers, J; Klarenbeek, S; van de Ven, M; van der Burg, E; van der Gulden, H	1

Other Studies

1 other study(ies) available for nimustine and Animal Mammary Carcinoma

Article	Year
Prophylactic window therapy with the clinical poly(ADP-ribose) polymerase inhibitor olaparib delays BRCA1-deficient mammary tumour formation in mice. The Journal of pathology, 2017, Volume: 241, Issue:4 Topics: Animals; Antineoplastic Agents; BRCA1 Protein; Cisplatin; Disease Models, Animal; DNA Repair; Female; Germ-Line Mutation; Humans; Mammary Neoplasms, Animal; Mice; Nimustine; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Tumor Suppressor Proteins	2017

Article

Year

Prophylactic window therapy with the clinical poly(ADP-ribose) polymerase inhibitor olaparib delays BRCA1-deficient mammary tumour formation in mice.

The Journal of pathology, 2017, Volume: 241, Issue:4

Topics: Animals; Antineoplastic Agents; BRCA1 Protein; Cisplatin; Disease Models, Animal; DNA Repair; Female; Germ-Line Mutation; Humans; Mammary Neoplasms, Animal; Mice; Nimustine; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Tumor Suppressor Proteins

2017